- 著者
-
Masaharu Ishihara
Koichi Nakao
Yukio Ozaki
Kazuo Kimura
Junya Ako
Teruo Noguchi
Masashi Fujino
Satoshi Yasuda
Satoru Suwa
Kazuteru Fujimoto
Yasuharu Nakama
Takashi Morita
Wataru Shimizu
Yoshihiko Saito
Atsushi Hirohata
Yasuhiro Morita
Teruo Inoue
Atsunori Okamura
Masaaki Uematsu
Kazuhito Hirata
Kengo Tanabe
Yoshisato Shibata
Mafumi Owa
Kenichi Tsujita
Hiroshi Funayama
Nobuaki Kokubu
Ken Kozuma
Tetsuya Tobaru
Shigeru Oshima
Michikazu Nakai
Kunihiro Nishimura
Yoshihiro Miyamoto
Hisao Ogawa
on behalf of J-MINUET Investigators
- 出版者
- The Japanese Circulation Society
- 雑誌
- Circulation Journal (ISSN:13469843)
- 巻号頁・発行日
- vol.81, no.7, pp.958-965, 2017-06-23 (Released:2017-06-23)
- 参考文献数
- 24
- 被引用文献数
-
34
43
Background:According to troponin-based criteria of myocardial infarction (MI), patients without elevation of creatine kinase (CK), formerly classified as unstable angina (UA), are now diagnosed as non-ST-elevation MI (NSTEMI), but little is known about their outcomes.Methods and Results:Between July 2012 and March 2014, 3,283 consecutive patients with MI were enrolled. Clinical follow-up data were obtained up to 3 years. The primary endpoint was a composite of all-cause death, non-fatal MI, non-fatal stroke, cardiac failure and urgent revascularization for UA. There were 2,262 patients with ST-elevation MI (STEMI), 563 NSTEMI with CK elevation (NSTEMI+CK) and 458 NSTEMI without CK elevation (NSTEMI-CK). From day 0, Kaplan-Meier curves for the primary endpoint began to diverge in favor of NSTEMI-CK for up to 30 days. The 30-day event rate was significantly lower in patients with NSTEMI-CK (3.3%) than in STEMI (8.6%, P<0.001) and NSTEMI+CK (9.9%, P<0.001). Later, the event curves diverged in favor of STEMI. The event rate from 31 days to 3 years was significantly lower in patients with STEMI (19.8%) than in NSTEMI+CK (33.6%, P<0.001) and NSTEMI-CK (34.2%, P<0.001). Kaplan-Meier curves from 31 days to 3 years were almost identical between NSTEMI+CK and NSTEMI-CK (P=0.91).Conclusions:Despite smaller infarct size and better short-term outcomes, long-term outcomes of NSTEMI-CK after convalescence were as poor as those for NSTEMI+CK and worse than for STEMI.